Structure Therapeutics Inc. (GPCR)
↓ Download CSVKey ratios (FY2025)
-9.3%
Return on equity
| Metric (FY) | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Income | -$176.56M | -$158.23M | -$102.78M | -$52.56M | — |
| Net Income | -$141.20M | -$122.53M | -$89.62M | -$51.32M | — |
| EPS (Diluted) | $-0.80 | $-0.78 | $-0.81 | $-5.51 | — |
| Total Assets | $1.58B | $903.33M | $482.02M | $97.84M | — |
| Total Liabilities | $67.54M | $38.49M | $29.05M | $13.01M | — |
| Shareholders' Equity | $1.52B | $864.84M | $452.97M | -$115.14M | -$64.73M |
| Cash & Equivalents | $799.62M | $169.51M | $129.79M | $26.09M | — |
| Operating Cash Flow | -$222.20M | -$116.64M | -$79.49M | -$46.12M | — |
| Capital Expenditures | $3.61M | $1.29M | $2.17M | $155.0K | — |
| Shares Outstanding | 212.51M | 171.86M | 139.22M | 10.53M | — |